HIV Research for Prevention 2014:
AIDS Vaccine, Microbicide and ARV-based Prevention Science
HIVR4P 2014 was held at the Cape Town International Convention Centre in Cape Town, South Africa, 28 - 31 October 2014. This premiere, biennial HIVR4P conference was the first global scientific meeting dedicated exclusively to biomedical HIV prevention research, including HIV vaccines, microbicides, PrEP, treatment as prevention and other biomedical prevention approaches. The conference was designed to build on and link to the successes of the past microbicide and vaccine conferences, which it replaces, while also responding to a growing consensus that effective HIV prevention will require a combination of approaches. With that in mind, HIVR4P set out to support cross-fertilization between different biomedical prevention approaches, identify the synergies and crosscutting challenges related to each, and provide a venue to discuss the research findings, questions and priorities specific to each modality, and to global HIV prevention efforts as a whole. From emerging areas in immunity and differential uses of antibodies to multipurpose technologies, combination prevention and changing definitions of “safer sex,” the conference program sought to include every major facet of a rapidly evolving biomedical HIV prevention paradigm.
HIVR4P worked to extend its reach through a number of mechanisms designed to make its research findings and the perspectives of its key speakers available to a global audience. All conference sessions were webcasted and conference posters were available through an electronic, user-friendly, open access archive, which made the conference fully accessible to a global audience, free of charge. Webcasts and ePosters can be accessed through the buttons above.